Strategic Partnerships |
Cancer Information GroupAll of CIG's peer-reviewed journals feature international editorial boards composed of prominent thought leaders in their respective fields. The indexed medical journals provide physicians and healthcare professionals with the most up-to-date, clinically relevant information available and include original study content, comprehensive reviews from research experts, meeting highlights from prominent conferences, expert panels, and current trials. All of the CIG journals are available and searchable from the MedTrust portal. DellDell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services they trust and value. Uniquely enabled by its direct business model, Dell is a leading global systems and services company and No. 34 on the Fortune 500. For more information, visit www.dell.com, or to communicate directly with Dell via a variety of online channels, go towww.dell.com/conversations. To get Dell news direct, visit www.dell.com/RSS. Intervention InsightsIntervention Insights provides actionable strategies that assist community oncologists in developing personalized treatments for their patients. By analyzing cancerous tissue, we generate a complete genomic picture of over 20,000 genes and corresponding molecular pathways that uniquely define a person’s cancer and the drugs that target them. We deliver this information to our frontline oncology partners who can quickly review hundreds of drugs which specifically target the molecular basis of a person’s cancer. Intervention Insights was created to support our community oncology partners with the best information for their patients' fight against cancer. MedTrust results providing supporting evidence for Intervention Insights drug list are included as a part of the OncInsights report. http://www.interventioninsights.com/ NexCuraWhen patients, caregivers and providers face critical treatment choices, NexCura delivers the timely, targeted, evidence-based and personally relevant knowledge they need. Using patented technology the NexProfiler™ treatment option tools generate individualized treatment options information based on peer-reviewed clinical research. National Foundation for Cancer ResearchThe National Foundation for Cancer Research (NFCR) was founded in 1973 to support cancer research and public education relating to the prevention, early diagnosis, better treatments and ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Research for a Cure- Cures all types of cancers. OracleOracle PartnerNetwork is a global business network of more than 19,500 companies who deliver innovative software solutions based on Oracle software. Through access to Oracle's premier products, education, technical services, marketing and sales support, the Oracle PartnerNetwork program provides partners with the resources they need to be successful in today's global economy. Oracle partners are able to offer their customers leading-edge solutions backed by Oracle's position as the world's largest enterprise software company. Partners who are able to demonstrate superior product knowledge, technical expertise and a commitment to doing business with Oracle qualify for the Certified Partner levels. Oracle Partner Network. Physician Education ResourcePhysician Education Resource (PER) is the largest provider of oncology continuing medical education in the US. All of PER’s more than 100 online CME courses are available from the MedTrust portal. http://www.cancerlearning.com/ Scottsdale Clinical Research Institute at Scottsdale HealthcareScottsdale Healthcare is the not-for-profit parent organization of the Scottsdale Healthcare Osborn, Scottsdale Healthcare Shea and Scottsdale Healthcare Thompson Peak hospitals, Virginia G. Piper Cancer Center, Scottsdale Clinical Research Institute, Scottsdale Healthcare Home Health Services, Scottsdale Healthcare Community Health Services and Scottsdale Healthcare Foundation. START Center for Cancer CareThe Mission of START Center for Cancer Care is to provide quality research, diagnosis and treatment of cancers for the community of patients and clients we serve. START Center for Cancer Care offers a full range of treatment options for patients facing cancer treatment. We specialize in Medical Oncology, Hematology, Gynecologic Oncology, and Radiation Oncology, and our physicians stand ready to treat you with a full range of therapies including the most current research protocols. With over 100 years of combined experience, our staff is well equipped to help you and your family during your treatment regimen. Thomson ReutersThomson Reuters is the world's leading source of intelligent information to better manage the cost and quality of healthcare and accelerate scientific research and innovation. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. DRUGDEX®, the Thomson Reuters drug compendium provided within Oncocentric, is the most comprehensive source of referenced drug information for evidence-based practice and a recognized standard for drug utilization review and screening. DRUGDEX® provides additional validation of clinicians' chosen treatments from a recognized reference standard for Medicare Parts B and D and for Medicaid. Translational Genomics Research InstituteThe Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. Van Andel InstituteFounded by Jay and Betty Van Andel, Van Andel Institute’s goal is to have an impact world-wide on medical science and education. The Institute supports Van Andel Research Institute (VARI) and Van Andel Education Institute (VAEI) in achieving this goal. VARI conducts biomedical research, with a focus on cancer and Parkinson disease and with an emphasis on translating scientific research results into clinical applications. VAEI strengthens science education and prepares and motivates individuals to pursue science or science-related professions. Van Andel scientists and MedTrust personnel are collaborating on projects focused in improving cancer outcomes. Located in downtown Grand Rapids, Michigan, the Institute has led the expansion of the life science industry in this region. Collaborative partnerships among world-class health care, research, and educational organizations have led to dramatic growth in the life sciences sector in the region, making Grand Rapids a career destination choice in this area. VelosVelos Inc. is a leading provider of next-generation healthcare software. Velos provides an integrated suite of clinical, administrative, and financial products. Velos eResearch, the company's flagship product line, is a comprehensive clinical research management information system. Velos' specialty medical product line supports the information needs of healthcare providers in cardiology, cardiovascular surgery, dialysis, and transplantation. MedTrust Online is always seeking partners to complement our comprehensive physician portal. The MedTrust Online solution designed to help oncologists with therapeutic decisions at the time of diagnosis is also proving equally valuable for pharmaceutical, biotech and medical device companies as well as physician groups, publishers and other business entities. Contact MedTrust Online to begin the process of becoming a strategic partner. |